RAS and CSF3R mutations in severe congenital neutropenia.
Germeshausen
Manuela
M
Kratz
Christian P
CP
Ballmaier
Matthias
M
Welte
Karl
K
D005260:Female; D030342:Genetic Diseases, Inborn / Q000150:complications / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D007938:Leukemia / Q000209:etiology / Q000235:genetics / Q000378:metabolism; D008297:Male; D009190:Myelodysplastic Syndromes / Q000209:etiology / Q000235:genetics / Q000378:metabolism; D009503:Neutropenia / Q000150:complications / Q000235:genetics* / Q000378:metabolism; D017354:Point Mutation; D011518:Proto-Oncogene Proteins / Q000235:genetics* / Q000378:metabolism; D016283:Proto-Oncogene Proteins p21(ras); D016184:Receptors, Colony-Stimulating Factor / Q000235:genetics* / Q000378:metabolism; D018631:ras Proteins / Q000235:genetics* / Q000378:metabolism
C517047:CSF3R protein, human; C117307:KRAS protein, human; D011518:Proto-Oncogene Proteins; D016184:Receptors, Colony-Stimulating Factor; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins